Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 10/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.46 |
| ▸ | CCR6 | P51684 | 3/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13768417 | 0.91 | EPHX2 (0.53) | GAAEPHX2EPHX1LMNAUSP2 | |
| SCHEMBL4011026 | 0.90 | GAA (0.62) | GAAEPHX2EPHX1LMNAUSP2 | |
| SCHEMBL13768773 | 0.83 | LMNA (0.56) | GAAEPHX2EPHX1LMNAUSP2 | |
| SCHEMBL14070435 | 0.81 | EPHX2 (0.52) | GAAEPHX2EPHX1LMNAUSP2 | |
| SCHEMBL4013218 | 0.80 | LMNA (0.63) | GAAEPHX2EPHX1LMNAUSP2 | |
| SCHEMBL13768400 | 0.79 | EPHX2 (0.52) | EPHX2EPHX1LMNAUSP2ALDH1A1 | |
| SCHEMBL4010903 | 0.79 | LMNA (0.69) | GAAEPHX2EPHX1LMNAUSP2 | |
| SCHEMBL13768771 | 0.78 | EPHX2 (0.58) | EPHX2EPHX1LMNAUSP2 | |
| SCHEMBL14071384 | 0.77 | USP2 (0.51) | EPHX2EPHX1LMNAUSP2 | |
| SCHEMBL14071386 | 0.77 | HSD11B1 (0.51) | EPHX2EPHX1LMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009086426-A2 | SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION | ARETE THERAPEUTICS, INC. (US) | 2009-07-09 | — | — | WO | disclosed |